|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.13 USD | -0.84% |
|
-11.33% | -1.81% |
| 13/01 | Sarepta reconfirms yearly sales floor for Elevidys of $500.0 mln | RE |
| 13/01 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
EPS & Dividend: Sarepta Therapeutics, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.11 | -5.15 | -8.03 | -5.8 | 2.34 | -5.325 | 2.037 | 1.916 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 170.49 | 90.05 | 129.58 | 96.43 | 121.59 | 21.13 | 21.13 | 21.13 |
| Nbr of stocks (in thousands) | 78,913 | 87,077 | 87,783 | 93,547 | 95,520 | 1,04,787 | 1,04,787 | - |
| Announcement Date | 01/03/21 | 01/03/22 | 28/02/23 | 28/02/24 | 26/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Sarepta Therapeutics, Inc.
| 03/03/2026 | Q4 2025 Earnings Release (Projected) |
| 06/05/2026 | Q1 2026 Earnings Release (Projected) |
| 05/08/2026 | Q2 2026 Earnings Release (Projected) |
| 04/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -3.97x | 1.97x | 1.37x | ||
| -.--% | -.--% | -3.94x | 14.42x | 2.18x | ||
| - | - | - | - | - | ||
| - | - | - | - | - | ||
| - | - | - | - | - | ||
| Average | 0% | 0% | -3.95x | 8.19x | 1.77x | |
| Weighted average by Cap. | 0% | 0% | -3.95x | 8.12x | 1.77x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















